Point72 Middle East Fze Pfizer Inc Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.6 Million - $2.07 Million	-61,100 Reduced 26.8%	166,900 $4.81 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $365,826 - $427,614	11,400 Added 5.26%	228,000 $7.56 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $5.1 Million - $5.9 Million	-141,300 Reduced 39.48%	216,600 $7.94 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $13.3 Million - $17.4 Million	338,800 Added 1773.82%	357,900 $14.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $797,425 - $1.04 Million	19,100 New	19,100 $0

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.